Fig. 1 · Structure
Documents & Downloads
Emitefur
Anticancer Drug
Emitefur is an orally bioavailable anticancer agent that primarily targets tumor growth and proliferation. It has demonstrated efficacy in clinical settings, particularly for patients with advanced gastric cancer. This compound may be valuable in research related to gastric cancer therapies and the development of novel treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 110690-43-2 |
| Applications | Anticancer Drug |
| Formula | C28H19FN4O8 |
| Molecular Weight | 558.47 |
| Synonyms | BOF-A2 |
| SMILES | O=C(C1=CC=CC(C(N(C2=O)C(N(C=C2F)COCC)=O)=O)=C1)OC3=NC(OC(C4=CC=CC=C4)=O)=CC=C3C#N |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.